UC law students compete in first-ever Deal-Makers competition
At the end of spring semester, 30 students took part in the first-ever Deal-Makers Competition at the University of Cincinnati College of Law.
Led by Professor Sean Mangan, co-director of the Corporate Law Center, student participants worked with local attorneys, drafted purchase agreements, and negotiated with each other.
The students broke into six teams of which half were sellers and the other half buyers. After hearing instructions and receiving all necessary documentation on Friday afternoon, the students began drafting and negotiating their deals through Sunday.
The prompt of the competition was based on a real-life situation Mangan experienced while working as an attorney. He worked closely with fellow law professor Felix Chang to refine the scenario, and thus created the unique transactional competition. The target company was a local outdoor outfitters store being bought by a larger, regional store similar to REI Co-op.
Though students who participated did not receive class credit, they experience they had was invaluable. βIt was awesome to see so many students show up for an entire weekend not to earn credit, but to learn about transactional law and experience it firsthand,β Mangan said.
After reviewing the purchase agreements and other accompanying documents, Mangan and judges named Deal #4, consisting of rising 3Ls Michael Goldman, Edward Rivin, Lindsay Burley and Emily Hughes, as the winning deal. Winners will receive a $250 cash prize.
Related Stories
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
β2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,β Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.
Weight loss drugs help, but not on their own
January 5, 2026
Millions of Americans are on one type of weight loss drug or another, and a University of Cincinnati physician says there are things to know as we enter the new year. Malti Vij, MD, adjunct associate professor in the Department of Internal Medicine and provider at UC Health Primary Care in Mason, recently spoke to 91.7 WVXU News.